Last update 08 May 2025

αvβ5 x TERT

Basic Info

Related Targets
αvβ5TERT

Related

2
Drugs associated with αvβ5 x TERT
OBP-502
Target
TERT x αvβ5
Mechanism
TERT modulators [+1]
Active Org.
Oncolys BioPharma, Inc.Oncolys BioPharma, Inc. [+1]
Originator Org.
Okayama UniversityOkayama University [+1]
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
OBP-405
Target
TERT x αvβ3 x αvβ5
Mechanism
TERT modulators [+2]
Active Org.-
Originator Org.
Okayama UniversityOkayama University [+1]
Active Indication-
Inactive Indication
Neoplasms
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with αvβ5 x TERT
Login to view more data
100 Translational Medicine associated with αvβ5 x TERT
Login to view more data
0 Patents (Medical) associated with αvβ5 x TERT
Login to view more data
1
Literatures (Medical) associated with αvβ5 x TERT
01 Nov 2007Molecular CarcinogenesisQ2 · MEDICINE
3‐O‐methylfunicone produced by penicillium pinophilum affects cell motility of breast cancer cells, downregulating αvβ5 integrin and inhibiting metalloproteinase‐9 secretion
Q2 · MEDICINE

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free